John Meckfessel

John Meckfessel has over 20 years of experience in the pharmaceutical industry, with a focus on marketing and strategic leadership roles. John is currently the Vice President and Head of the Leukemia Franchise at Stemline Therapeutics since 2022. Prior to that, they worked at Jazz Pharmaceuticals as the Senior Director of Marketing - AML from 2020 to 2022, leading U.S. marketing efforts in the area of Acute Myeloid Leukemia. From 2016 to 2019, they served as the Global Marketing Director at Amgen. Before that, they held the position of Director of Global Strategic Marketing at Johnson & Johnson from 2012 to 2016. John also worked at Celgene as the Director of Marketing - Myeloma from 2010 to 2012 and as a District Sales Manager and Senior Product Manager from 2006 to 2010. Prior to that, they worked as a Sales Training Manager at Ortho Biotech from 2004 to 2006 and at Ortho Biotech Products, L.P., a Johnson & Johnson Company from 2002 to 2004.

John Meckfessel completed their Bachelor of Science degree in Business Administration and Economics at Saint Mary's College of California from 1991 to 1995. John then pursued further education, earning a Master of Business Administration (M.B.A.) degree with a focus on Business Administration and Management, General from California State University-Dominguez Hills between 1998 and 2000.